"Breakthrough in Pancreatic Cancer Treatment: Chinese Scientists Uncover Promising Protein Markers"

Chinese scientists have identified two protein markers that may predict chemotherapy sensitivity in pancreatic cancer, a discovery that could improve overall survival rates for the disease, which currently has a low five-year survival rate. The study, involving over 1,000 patients, sequenced the proteome and transcriptome to construct a model for pancreatic cancer prognosis and identified the biomarkers NDUFB8 and CEMIP2. The findings are expected to usher in a new era of precision diagnosis and treatment for pancreatic cancer, which is often diagnosed at advanced stages, limiting treatment options.